dc.contributor.author |
Cloete, Hester |
en |
dc.contributor.author |
Gentles, TL |
en |
dc.contributor.author |
Bloomfield, Francis |
en |
dc.date.accessioned |
2020-04-09T01:13:58Z |
en |
dc.date.issued |
2020-01-17 |
en |
dc.identifier.citation |
New Zealand Medical Journal 133(1508):111-117 17 Jan 2020 |
en |
dc.identifier.issn |
0028-8446 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/50339 |
en |
dc.description.abstract |
The mortality risk for infants with critical congenital heart disease (CCHD) unrecognised at the time of birth is high. Pulse oximetry has been utilised as a screening tool for the detection of these anomalies in the newborn as the majority will have a degree of hypoxaemia. This screening strategy has a moderate sensitivity and excellent specificity for the detection of CCHD, and a low false-positive rate. Respiratory and infective diseases are responsible for a large number of positive test results. The early recognition of these diseases can also improve health outcomes. Di erent approaches have been taken to introduce screening, ranging from hospital-led initiatives to mandatory state-wide policies. A study conducted in New Zealand demonstrated that sector-led screening initiatives are unlikely to result in equitable outcomes. In this midwifery-led maternity setting a nationwide pulse oximetry screening programme with adequate human and material resources should be introduced. |
en |
dc.language |
English |
en |
dc.publisher |
New Zealand Medical Association |
en |
dc.relation.ispartofseries |
New Zealand Medical Journal |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
https://www.nzma.org.nz/pages/articles |
en |
dc.subject |
Science & Technology |
en |
dc.subject |
Life Sciences & Biomedicine |
en |
dc.subject |
Medicine, General & Internal |
en |
dc.subject |
General & Internal Medicine |
en |
dc.subject |
QUALITY IMPROVEMENT |
en |
dc.subject |
IMPLEMENTATION |
en |
dc.subject |
ASSOCIATION |
en |
dc.subject |
DEFECTS |
en |
dc.title |
New Zealand should introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease and other hypoxaemic conditions in the newborn |
en |
dc.type |
Journal Article |
en |
pubs.issue |
1508 |
en |
pubs.begin-page |
111 |
en |
pubs.volume |
133 |
en |
dc.rights.holder |
Copyright: NZMA |
en |
pubs.author-url |
https://www.nzma.org.nz/journal-articles/new-zealand-should-introduce-nationwide-pulse-oximetry-screening-for-the-detection-of-critical-congenital-heart-disease-and-other-hypoxaemic-conditions-in-the-newborn |
en |
pubs.end-page |
117 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
794253 |
en |
pubs.org-id |
Liggins Institute |
en |
pubs.org-id |
LiFePATH |
en |
dc.identifier.eissn |
1175-8716 |
en |
pubs.record-created-at-source-date |
2020-05-26 |
en |